189 related articles for article (PubMed ID: 16613193)
1. [Anti-platelet drugs (aspirin, ticlopidine, etc)].
Ikeda U
Nihon Rinsho; 2006 Apr; 64(4):743-7. PubMed ID: 16613193
[TBL] [Abstract][Full Text] [Related]
2. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
5. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
6. [In acute coronary syndrome. Seize platelets with pliers].
MMW Fortschr Med; 2002 Nov; 144(45):61. PubMed ID: 12534069
[No Abstract] [Full Text] [Related]
7. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
[No Abstract] [Full Text] [Related]
8. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
[No Abstract] [Full Text] [Related]
9. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
[TBL] [Abstract][Full Text] [Related]
10. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
11. [Antiplatelet therapy in cardiac diseases].
Aosaki M; Iwade K; Kimata S; Hosoda S
Nihon Rinsho; 1992 Feb; 50(2):397-402. PubMed ID: 1613997
[TBL] [Abstract][Full Text] [Related]
12. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
13. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
14. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
16. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
[No Abstract] [Full Text] [Related]
17. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
19. Role of antiplatelet drugs in the prevention of cardiovascular events.
Tendera M; Wojakowski W
Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
[TBL] [Abstract][Full Text] [Related]
20. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
